JP Patent

JP4350946B2 — 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体

Assigned to Merck and Co Inc · Expires 2009-10-28 · 17y expired

What this patent protects

Patent listed against Velsipity.

Drugs covered by this patent

Velsipity (Etrasimod Arginine) · Pfizer Inc.

Patent Metadata

Patent number: JP4350946B2
Jurisdiction: JP
Classification: —
Expires: 2009-10-28
Drug substance claim: No
Drug product claim: No
Assignee: Merck and Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.